Severe anaemia complicating HIV in Malawi; Multiple co-existing aetiologies are associated with high mortality.

Minke H W Huibers, Imelda Bates, Steve McKew, Theresa J Allain, Sarah E Coupland, Chimota Phiri, Kamija S Phiri, Michael Boele van Hensbroek, Job C Calis

Journal: PloS one 2020;15(2):e0218695

PMID: 32097440

Abstract

BACKGROUND

Severe anaemia is a major cause of morbidity and mortality in HIV-infected adults living in resource-limited countries. Comprehensive data on the aetiology are lacking but are needed to improve outcomes.

METHODS

HIV-infected adults with severe (haemoglobin ≤70g/l) or very severe anaemia (haemoglobin ≤ 50 g/l) were recruited at Queen Elizabeth Central Hospital, Blantyre, Malawi. Fifteen potential causes and associations with anaemia severity and mortality were explored.

RESULTS

199 patients were enrolled: 42.2% had very severe anaemia and 45.7% were on ART. More than two potential causes for anaemia were present in 94% of the patients including iron deficiency (55.3%), underweight (BMI<20: 49.7%), TB infection (41.2%) and unsuppressed HIV infection (viral load >1000 copies/ml) (73.9%). EBV/CMV co-infection (16.5%) was associated with very severe anaemia (OR 2.8 95% CI 1.1-6.9). Overall mortality was high (53%; 100/199) with a median time to death of 17.5 days (IQR 6-55) days. Death was associated with folate deficiency (HR 2.2; 95% CI 1.2-3.8) and end stage renal disease (HR 3.2; 95% CI 1.6-6.2).

CONCLUSION

Mortality among severely anaemic HIV-infected adults is strikingly high. Clinicians should be aware of the urgent need for a multifactorial approach including starting or optimising HIV treatment, considering TB treatment, nutritional support and optimising renal management.

Address: Global child health group, Emma Children's Hospital, University Medical Centres Amsterdam, location Academic Medical Centre, University of Amsterdam, The Netherlands.; Amsterdam Institute of Global Health Development, Amsterdam, the Netherlands.; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Department of Internal Medicine, Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, United Kingdom.; Department of Internal Medicine, College of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.; Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.; Department of Pathology, Royal Liverpool University Hospital, Liverpool, United Kingdom.; School of Public Health and Family Medicine, College of Medicine, Blantyre, Malawi.; Department of Pediatric Intensive Care, Emma Children's Hospital, Academic Medical Centre, University of Amsterdam, The Netherlands.; Department of Paediatrics, College of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.